Scientists are now working towards
developing efficient vaccines out of
'complements', proteins which safeguard against disease-causing
pathogens (New Scientist, Vo1149,
Douglas Fearon and his team at the University of Cambridge, UK, and immunologists from Stanford University in Palo Alto, California, US, are experimenting with the complement protein C3. They believe that if pieces of C3 are attatched to a simple protein, it would transform the protein into 'immunological enemy number one'.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.